Literature DB >> 18204349

Toxic epidermal necrolysis and fluoxetine: a case report.

Gregory W Jonsson1, Mahomed Y Moosa, Fatima Y Jeenah.   

Abstract

Toxic epidermal necrolysis (TEN) is a distinct clinical entity within a spectrum of adverse cutaneous drug reactions. It is characterized by >30% of the body surface area of skin detachment with an average reported mortality of 25-35%. Drug induced TEN is associated with various antibiotics, anticonvulsants and other drugs. While adverse cutaneous drug reactions are common with antidepressants, the majority eruptions are benign and easily treated. TEN is rarely reported in association with selective serotonin reuptake inhibitors (SSRI's). We describe TEN in a 34-year-old patient from Mozambique associated with the addition of fluoxetine for a major depressive episode with psychotic features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204349     DOI: 10.1097/jcp.0b013e3181604015

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  4 in total

1.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

Review 2.  [Obstacles in investigating a drug induced toxiderma using Bégaud's method in psychiatry. About a case report and a review of the literature].

Authors:  Djibo Douma Maiga; Laouali Salissou; Mamane Daou
Journal:  Pan Afr Med J       Date:  2014-03-21

3.  An Interesting Case of Carbamazepine-Induced Stevens-Johnson Syndrome.

Authors:  Josiah Tatenda Masuka; Garikai Muzopambwa; Star Khoza; Dixon Chibanda
Journal:  Drug Saf Case Rep       Date:  2018-12-10

Review 4.  Severe skin complications in patients treated with antidepressants: a literature review.

Authors:  Marta Herstowska; Olivia Komorowska; Wiesław J Cubała; Katarzyna Jakuszkowiak-Wojten; Maria Gałuszko-Węgielnik; Jerzy Landowski
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.